secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001567264-25-000069
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics annual meeting results: director elected, auditor ratified
--------------------------------------------------------------------------------

- Mark A. Goldberg elected Class II director with 6,979,703 votes For, 222,974 Withheld.
- EisnerAmper LLP ratified as independent auditor for FY2025; 10,929,292 For, 16,730 Against.
- Approximately 59.73% of outstanding shares represented at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000069/0001567264-25-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000069/intensity-20250717.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer